Abstract: The present invention relates to methods for detecting a psychiatric condition optionally associated with a depression comprising the steps of measuring the concentration of at least one in vivo degradation product of tryptophan. Further, the present invention relates to the use of said values as predictive markers for the detection of a psychiatric condition optionally associated with a depression and a kit containing means for detecting said values.
Type:
Application
Filed:
February 21, 2012
Publication date:
August 2, 2012
Applicants:
DIAMED-EUROGEN N.V., Klinik und Poliklinik fur Psychiatrie und Psychotherapie, UNIVERSITY OF ANTWERP, UNIVERSITY OF MAASTRICHT
Inventors:
Aye Mu Myint, Manfred Schawaller, Robert Verkerk, Markus J. Schwarz, Harald Hampel, Norbert Müller
Abstract: The present invention relates to methods for detecting a psychiatric condition optionally associated with a depression comprising the steps of measuring the concentration of at least one in vivo degradation product of tryptophan. Further, the present invention relates to the use of said values as predictive markers for the detection of a psychiatric condition optionally associated with a depression and a kit containing means for detecting said values.
Type:
Application
Filed:
March 30, 2006
Publication date:
June 5, 2008
Applicants:
Diamed-Eurogen N. V., University of Maastricht, University of Antwerp, Stiftung fur Diagnostische Forschung, Klinik und Poliklinik fur Psychiatrie und Psychotherapie
Inventors:
Aye Mu Myint, Manfred Schawaller, Robert Verkerk, Markus J. Schwarz, Harald Hampel, Norbert Muller